The company had a net profit of Rs 44.61 crore for the same period in the previous fiscal, JB Chemicals & Pharmaceuticals said in a filing to the Bombay Stock Exchange (BSE).
As the company sold its Russia-CIS OTC business to Cilag GmbH International, a subsidiary of US-based Johnson and Johnson for Rs 754.53 crore, the results of the current quarter are not comparable with the same period previous fiscal.
1790
2166
148
399
249
499
395
1200
500
0
378
899
375
0
244
399
138
250
1675
1800
13923
27799